Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 58,316 | 61,793 | 52,048 | 47,165 | 36,662 |
| Cost of Goods | 17,580 | 18,968 | 20,391 | 19,954 | 18,127 |
| Gross Profit | 40,736 | 42,825 | 31,657 | 27,211 | 18,535 |
| Operating Expenses | 37,975 | 35,873 | 33,033 | 31,007 | 27,920 |
| Operating Income | 3,341 | 7,920 | -985 | -2,842 | -9,258 |
| Interest Expense | 1,996 | 2,055 | 2,037 | 2,079 | 2,107 |
| Other Income | -33 | 110 | 18 | -116 | -112 |
| Pre-tax Income | 1,312 | 5,975 | -3,004 | -5,037 | -11,477 |
| Income Tax | 52 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 1,260 | 5,802 | -3,004 | -5,037 | -11,477 |
| Net Income | $1,260 | $5,802 | $-3,004 | $-5,037 | $-11,477 |
| EPS Basic Total Ops | 0.03 | 0.17 | -0.08 | -0.14 | -0.34 |
| EPS Basic Continuous Ops | 0.03 | 0.18 | -0.08 | -0.14 | -0.34 |
| EPS Diluted Total Ops | 0.03 | 0.17 | -0.08 | -0.14 | -0.34 |
| EPS Diluted Continuous Ops | 0.03 | 0.18 | -0.08 | -0.14 | -0.34 |
| EBITDA(a) | $7,241 | $11,784 | $2,564 | $646 | $-5,498 |